Global Hemostats Market Report and Forecast 2023-2031
Global Hemostats Market Outlook
The global hemostats market value in 2022 was USD 4 billion driven by the increasing number of surgical procedures across the globe. The market is anticipated to grow at a CAGR of 6.6% during the forecast period of 2023-2031 to achieve a value of USD 7.1 billion by 2031.
Hemostats Introduction
Hemostats are medical devices or agents used to control bleeding during surgical procedures or traumatic injuries by promoting blood clot formation, sealing blood vessels, or mechanically compressing blood vessels. Hemostats can be classified into several categories, including mechanical hemostats, active hemostats, flowable hemostats, and sealants. They are widely used across various surgical specialties, such as general surgery, cardiovascular surgery, orthopedic surgery, and neurosurgery.
Hemostats Market Scenario
The global market has experienced significant growth in recent years, driven by factors such as the increasing number of surgical procedures, an aging global population, advancements in hemostatic materials and technologies, and growing awareness about the importance of proper bleeding control in surgical outcomes.
North America is the largest market for hemostats, driven by factors such as the advanced healthcare infrastructure, a high number of surgical procedures, and the presence of major hemostat manufacturers.
Europe is the second-largest market, with increasing demand for hemostats due to a growing aging population and a supportive regulatory framework.
Asia Pacific is expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.
Hemostats Market Segmentations
Market Breakup by Product Type
- Combination
- Thrombin Based
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
- Matrix and Gel
- Sheet and Pad
- Sponge
- Powder
- Others
- Orthopedic
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
- Closure
- Surgery
- Ambulatory Centres
- Hospitals
- Clinics
- Community Healthcare
- Others
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Hemostats Market
Some key trends of the market are as follows:
- Advancements in hemostatic materials and technologies: The development of new hemostatic materials, such as advanced biologics and combination products, has improved the performance, safety, and patient outcomes of hemostats, contributing to market expansion.
- Growing demand for minimally invasive surgical procedures: The increasing preference for minimally invasive surgical procedures, which typically require specialized hemostatic solutions, has driven market growth and innovation.
- Rising awareness about proper bleeding control: Increasing awareness about the importance of proper bleeding control, particularly in the prevention of complications and improvement of surgical outcomes, has led to greater demand for advanced hemostats.
Hemostats Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- CR Bard, Inc.
- B. Braun Melsungen AG
- Baxter International, Inc.
- Integra Life Sciences
- Marine Polymer Technologies, Inc.
- Teleflex
- Ethicon, Inc.
- Pfizer, Inc.
- Z-Medica LLC
- Gelita Medical GmbH
- Anika Therapeutics, Inc.
- Stryker
- Integra Lifesciences Corporation
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Hemostats Market Overview
- 3.1 Global Hemostats Market Historical Value (2016-2022)
- 3.2 Global Hemostats Market Forecast Value (2023-2031)
- 4 Global Hemostats Market Landscape
- 4.1 Global Hemostats Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Hemostats Product Landscape
- 4.2.1 Analysis by Product Type
- 4.2.2 Analysis by Formulation
- 4.2.3 Analysis by Applications
- 5 Global Hemostats Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Hemostats Market Segmentation
- 6.1 Global Hemostats Market by Product Type
- 6.1.1 Market Overview
- 6.1.2 Combination
- 6.1.3 Thrombin Based
- 6.1.4 Oxidized Regenerated Cellulose Based
- 6.1.5 Gelatin Based
- 6.1.6 Collagen Based
- 6.1.7 Others
- 6.2 Global Hemostats Market by Formulation
- 6.2.1 Market Overview
- 6.2.2 Matrix and Gel
- 6.2.3 Sheet and Pad
- 6.2.4 Sponge
- 6.2.5 Powder
- 6.2.6 Others
- 6.3 Global Hemostats Market by Applications
- 6.3.1 Market Overview
- 6.3.2 Orthopedic
- 6.3.3 General Surgery
- 6.3.4 Neurological Surgery
- 6.3.5 Cardiovascular Surgery
- 6.3.6 Reconstructive Surgery
- 6.3.7 Gynecological Surgery
- 6.3.8 Others
- 6.4 Global Hemostats Market by Indications
- 6.4.1 Market Overview
- 6.4.2 Closure
- 6.4.3 Surgery
- 6.5 Global Hemostats Market by End User
- 6.5.1 Market Overview
- 6.5.2 Ambulatory centers
- 6.5.3 Hospitals
- 6.5.4 Clinics
- 6.5.5 Community healthcare
- 6.5.6 Others
- 6.6 Global Hemostats Market by Region
- 6.6.1 Market Overview
- 6.6.2 North America
- 6.6.3 Europe
- 6.6.4 Asia Pacific
- 6.6.5 Latin America
- 6.6.6 Middle East and Africa
- 7 North America Hemostats Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Hemostats Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Hemostats Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Hemostats Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Hemostats Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 CR Bard, Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 B. Braun Melsungen AG
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Baxter International, Inc.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Integra Life Sciences
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Marine Polymer Technologies, Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Teleflex
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Ethicon, Inc.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Pfizer, Inc.
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Z-Medica LLC
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Gelita Medical GmbH
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Anika Therapeutics, Inc.
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Stryker
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 Integra Lifesciences Corporation
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 18 Global Hemostats Market-Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Pricing Models and Strategies (Additional Insight)
- 21.1 Overview
- 21.2 Cost Model
- 21.2.1 Manufacturing Cost Analysis
- 21.2.2 Procurement Cost Analysis
- 21.2.3 Clinical Trial Cost Factors
- 21.3 Pricing Strategies
- 21.3.1 Competitor Pricing Analysis
- 21.3.2 Key Assessment of Product Attributes
- 21.3.3 Pricing Benchmark
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook